Advertisement
FSPKF vs TMDX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPKF is a Hold and TMDX is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FSPKF’s FA Score shows that 0 FA rating(s) are green whileTMDX’s FA Score has 0 green FA rating(s).
- FSPKF’s FA Score: 0 green, 5 red.
- TMDX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FSPKF’s TA Score shows that 4 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).
- FSPKF’s TA Score: 4 bullish, 3 bearish.
- TMDX’s TA Score: 4 bullish, 6 bearish.
Price Growth
FSPKF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while TMDX (@Medical/Nursing Services) price change was -5.02% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.
Reported Earning Dates
TMDX is expected to report earnings on Nov 11, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+1.86% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.03% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| FSPKF | TMDX | FSPKF / TMDX | |
| Capitalization | 12.8B | 3.9B | 328% |
| EBITDA | 654M | 112M | 584% |
| Gain YTD | -0.941 | 83.641 | -1% |
| P/E Ratio | 52.84 | 57.54 | 92% |
| Revenue | 1.28B | 531M | 241% |
| Total Cash | 264M | 401M | 66% |
| Total Debt | 153M | 519M | 29% |
FSPKF | TMDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 50 | |
SMR RATING 1..100 | 46 | 35 | |
PRICE GROWTH RATING 1..100 | 60 | 53 | |
P/E GROWTH RATING 1..100 | 96 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TMDX's Valuation (78) in the Medical Specialties industry is in the same range as FSPKF (94) in the null industry. This means that TMDX’s stock grew similarly to FSPKF’s over the last 12 months.
TMDX's Profit vs Risk Rating (50) in the Medical Specialties industry is somewhat better than the same rating for FSPKF (100) in the null industry. This means that TMDX’s stock grew somewhat faster than FSPKF’s over the last 12 months.
TMDX's SMR Rating (35) in the Medical Specialties industry is in the same range as FSPKF (46) in the null industry. This means that TMDX’s stock grew similarly to FSPKF’s over the last 12 months.
TMDX's Price Growth Rating (53) in the Medical Specialties industry is in the same range as FSPKF (60) in the null industry. This means that TMDX’s stock grew similarly to FSPKF’s over the last 12 months.
FSPKF's P/E Growth Rating (96) in the null industry is in the same range as TMDX (100) in the Medical Specialties industry. This means that FSPKF’s stock grew similarly to TMDX’s over the last 12 months.
| FSPKF | TMDX | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 70% | 4 days ago 86% |
| Stochastic ODDS (%) | 4 days ago 52% | 4 days ago 73% |
| Momentum ODDS (%) | 4 days ago 52% | 4 days ago 89% |
| MACD ODDS (%) | 4 days ago 49% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 52% | 4 days ago 82% |
| TrendMonth ODDS (%) | 4 days ago 43% | 4 days ago 85% |
| Advances ODDS (%) | N/A | 11 days ago 84% |
| Declines ODDS (%) | N/A | 4 days ago 81% |
| BollingerBands ODDS (%) | N/A | 4 days ago 80% |
| Aroon ODDS (%) | N/A | 4 days ago 86% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LMTIX | 25.93 | 0.26 | +1.01% |
| Franklin U.S. Large Cap Equity I | |||
| HIACX | 56.18 | 0.36 | +0.64% |
| Hartford Capital Appreciation HLS IA | |||
| EPLDX | 22.59 | 0.13 | +0.58% |
| NYLI Epoch U.S. Equity Yield Class R6 | |||
| TGVNX | 29.02 | 0.16 | +0.55% |
| TCW Relative Value Mid Cap N | |||
| NEWFX | 89.86 | -0.01 | -0.01% |
| American Funds New World A | |||
FSPKF and
Correlation & Price change
A.I.dvisor tells us that FSPKF and TMDX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSPKF and TMDX's prices will move in lockstep.
| Ticker / NAME | Correlation To FSPKF | 1D Price Change % | ||
|---|---|---|---|---|
| FSPKF | 100% | N/A | ||
| TMDX - FSPKF | 29% Poorly correlated | -1.34% | ||
| APYX - FSPKF | 25% Poorly correlated | +11.22% | ||
| BRSYF - FSPKF | 24% Poorly correlated | N/A | ||
| ANSLY - FSPKF | 22% Poorly correlated | N/A | ||
| GTHP - FSPKF | 22% Poorly correlated | -17.11% | ||
More | ||||
TMDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with AXGN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then AXGN could also see price increases.
| Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
|---|---|---|---|---|
| TMDX | 100% | -1.34% | ||
| AXGN - TMDX | 39% Loosely correlated | -1.21% | ||
| RDNT - TMDX | 37% Loosely correlated | +1.58% | ||
| SMTI - TMDX | 33% Loosely correlated | +1.81% | ||
| NNOX - TMDX | 33% Poorly correlated | +0.65% | ||
| NVST - TMDX | 30% Poorly correlated | +0.75% | ||
More | ||||